AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
ANTIDIARRHEAL AGENTS FOR THE MANAGEMENT OF TREATMENT-RELATED DIARRHEAIN CANCER-PATIENTS
Authors: IPPOLITI C
Citation: C. Ippoliti, ANTIDIARRHEAL AGENTS FOR THE MANAGEMENT OF TREATMENT-RELATED DIARRHEAIN CANCER-PATIENTS, American journal of health-system pharmacy, 55(15), 1998, pp. 1573-1580
TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES
Authors: KHOURI IF KEATING M KORBLING M PRZEPIORKA D ANDERLINI P OBRIEN S GIRALT S IPPOLITI C VONWOLFF B GAJEWSKI J DONATO M CLAXTON D UENO N ANDERSSON B GEE A CHAMPLIN R
Citation: If. Khouri et al., TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2817-2824
PHASE-II STUDY OF DACLIZUMAB FOR TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE
Authors: PRZEPIORKA D KERNAN N IPPOLITI C PAPADOPOULOS E GIRALT S KHOURI I LU J GAJEWSKI J DURETT A CLEARY R CHAMPLIN R ANDERSSON B LIGHT S
Citation: D. Przepiorka et al., PHASE-II STUDY OF DACLIZUMAB FOR TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE, Experimental hematology, 26(8), 1998, pp. 35-35
PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC)
Authors: GAJEWSKI J RONDON G MIRZA N MEHRA R DONATO M ANDERLINI P KORBLING M THERIALT R KHOURI I GIRALT S BUZDAR A UENO N PRZEPIORKA D ANDERSSON B DURRETT A SALIBA R BRUTON J RAHMAN Z IPPOLITI C HORTABAQYI G RABER M BAST R CHAMPLIN R
Citation: J. Gajewski et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC), Experimental hematology, 26(8), 1998, pp. 371-371
IMPACT OF PROPHYLAXIS REGIMEN ON THE INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KHOURI I ANDERLINI P FOLLODER J UENO N MEHRA R GIRALT S GAJEWSKI J CLEARY K CLAXTON D CHAMPLIN R ANDERSSON B KORBLING M
Citation: D. Przepiorka et al., IMPACT OF PROPHYLAXIS REGIMEN ON THE INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 26-26
USE OF OCTREOTIDE IN THE SYMPTOMATIC MANAGEMENT OF DIARRHEA INDUCED BY GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: IPPOLITI C CHAMPLIN R BUGAZIA N PRZEPIORKA D NEUMANN J GIRALT S KHOURI I GAJEWSKI J
Citation: C. Ippoliti et al., USE OF OCTREOTIDE IN THE SYMPTOMATIC MANAGEMENT OF DIARRHEA INDUCED BY GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 15(11), 1997, pp. 3350-3354
FOSCARNET FOR PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS UNABLE TO RECEIVE GANCICLOVIR
Authors: IPPOLITI C MORGAN A WARKENTIN D VANBESIEN K MEHRA R KHOURI I GIRALT S GAJEWSKI J CHAMPLIN R ANDERSSON B PRZEPIORKA D
Citation: C. Ippoliti et al., FOSCARNET FOR PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS UNABLE TO RECEIVE GANCICLOVIR, Bone marrow transplantation, 20(6), 1997, pp. 491-495
TOXICITIES OF TACROLIMUS AND CYCLOSPORINE-A AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION
Authors: WOO M PRZEPIORKA D IPPOLITI C WARKENTIN D KHOURI I FRITSCHE H KORBLING M
Citation: M. Woo et al., TOXICITIES OF TACROLIMUS AND CYCLOSPORINE-A AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 20(12), 1997, pp. 1095-1098
HEADACHE, CIRCUMORAL PARESTHESIA, AND FACIAL FLUSHING ASSOCIATED WITHHIGH-DOSE CARMUSTINE INFUSION
Authors: WOO MH IPPOLITI C BRUTON J MEHRA R CHAMPLIN R PRZEPIORKA D
Citation: Mh. Woo et al., HEADACHE, CIRCUMORAL PARESTHESIA, AND FACIAL FLUSHING ASSOCIATED WITHHIGH-DOSE CARMUSTINE INFUSION, Bone marrow transplantation, 19(8), 1997, pp. 845-847
ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION IN ADVANCED HEMATOLOGIC CANCERS
Authors: PRZEPIORKA D ANDERLINI P IPPOLITI C KHOURI I FIETZ T THALL P MEHRA R GIRALT S GAJEWSKI J DEISSEROTH AB CLEARY K CHAMPLIN R VANBESIEN K ANDERSSON B KORBLING M
Citation: D. Przepiorka et al., ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION IN ADVANCED HEMATOLOGIC CANCERS, Bone marrow transplantation, 19(5), 1997, pp. 455-460
RISK-FACTORS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BLOOD STEM-CELL TRANSPLANT RECIPIENTS
Authors: PRZEPIORKA D ANDERLINI P IPPOLITI C KHOURI I FOLLODER J UENO N MEHRA R GIRALT S GAJEWSKI J CLEARY K CLAXTON D ANDERSSON B KORBLING M CHAMPLIN R
Citation: D. Przepiorka et al., RISK-FACTORS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BLOOD STEM-CELL TRANSPLANT RECIPIENTS, Blood, 90(10), 1997, pp. 441-441
DOSE-INTENSIFIED ANTITHYMOCYTE GLOBULIN (ATG) IN STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC MARROW OR BLOOD STEM-CELL TRANSPLANTATION
Authors: KIENAST J IPPOLITI C MEHRA R UENO N CHAMPLIN R KHOURI I GIRALT S GAJEWSKI J CLAXTON D ANDERLINI P ANDERSSON B PRZEPIORKA D
Citation: J. Kienast et al., DOSE-INTENSIFIED ANTITHYMOCYTE GLOBULIN (ATG) IN STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC MARROW OR BLOOD STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 457-457
RESULTS OF CD8 DEPLETED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (CD8- ALLO-PBSC) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: GIRALT S MIRZA N MEHRA R GAJEWSKI J ANDERSSON B PRZEPIORKA D KHOURI I KORBLING M COHEN A RAHMAN Z VANBESIEN K IPPOLITI C BRUTON J ANDERLINI P UENO N CHAMPLIN R
Citation: S. Giralt et al., RESULTS OF CD8 DEPLETED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (CD8- ALLO-PBSC) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 90(10), 1997, pp. 1657-1657
PRELIMINARY-RESULTS OF FLUDARABINE MELPHALAN OR 2CDA/MELPHALAN (2CDA/M) AS PREPARATIVE REGIMENS FOR ALLOGENEIC PROGENITOR-CELL TRANSPLANTATION (ALLO-PCT) IN POOR CANDIDATES FOR CONVENTIONAL MYELOABLATIVE CONDITIONING/
Authors: GIRALT S COHEN A MEHRA R GAJEWSKI J ANDERSSON B PRZEPIORKA D KHOURI I KORBLING M DAVIS M VANBESIEN K IPPOLITI C BRUTON J ANDERLINI P UENO N CHAMPLIN R
Citation: S. Giralt et al., PRELIMINARY-RESULTS OF FLUDARABINE MELPHALAN OR 2CDA/MELPHALAN (2CDA/M) AS PREPARATIVE REGIMENS FOR ALLOGENEIC PROGENITOR-CELL TRANSPLANTATION (ALLO-PCT) IN POOR CANDIDATES FOR CONVENTIONAL MYELOABLATIVE CONDITIONING/, Blood, 90(10), 1997, pp. 1853-1853
NEUTROPENIAS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - RESPONSE TO THERAPY WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
Authors: KHOURI IF IPPOLITI C GAJEWSKI J PRZEPIORKA D CHAMPLIN RE
Citation: If. Khouri et al., NEUTROPENIAS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - RESPONSE TO THERAPY WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN, American journal of hematology, 52(4), 1996, pp. 313-315
A CLINICAL-PHASE I II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR IN GLUCOCORTICOID-RESISTANT GRAFT-VERSUS-HOST DISEASE/
Authors: MCCARTHY PL WILLIAMS L HARRISBACILE M YEN J PRZEPIORKA D IPPOLITI C CHAMPLIN R FAY J BLOSCH C JACOBS C ANASETTI C
Citation: Pl. Mccarthy et al., A CLINICAL-PHASE I II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR IN GLUCOCORTICOID-RESISTANT GRAFT-VERSUS-HOST DISEASE/, Transplantation, 62(5), 1996, pp. 626-631
ALLOGENEIC TRANSPLANTATION FOR ADVANCED LEUKEMIA - IMPROVED SHORT-TERM OUTCOME WITH BLOOD STEM-CELL GRAFTS AND TACROLIMUS
Authors: PRZEPIORKA D IPPOLITI C KHOURI I ANDERLINI P MEHRA R GIRALT S GAJEWSKI J FRITSCHE H DEISSEROTH AB CLEARY K CHAMPLIN R VANBESIEN K ANDERSSON B KORBLING M
Citation: D. Przepiorka et al., ALLOGENEIC TRANSPLANTATION FOR ADVANCED LEUKEMIA - IMPROVED SHORT-TERM OUTCOME WITH BLOOD STEM-CELL GRAFTS AND TACROLIMUS, Transplantation, 62(12), 1996, pp. 1806-1810
TACROLIMUS AND MINIDOSE METHOTREXATE FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MATCHED UNRELATED DONOR MARROW TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KHOURI I WOO M MEHRA R LEBHERZ D GIRALT S GAJEWSKI J FISCHER H FRITSCHE H DEISSEROTH AB CLEAN K CHAMPLIN R VANBESIEN K ANDERSSON B MAHER R FITZSIMMONS W
Citation: D. Przepiorka et al., TACROLIMUS AND MINIDOSE METHOTREXATE FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MATCHED UNRELATED DONOR MARROW TRANSPLANTATION, Blood, 88(11), 1996, pp. 4383-4389
STANDARD PRACTICE PROTOCOL OF GRANISETRON (KYTRIL(R)) FOR ANTIEMETIC CONTROL IN BONE-MARROW TRANSPLANT (BMT) PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION (TBI)
Authors: ABBOTT B IPPOLITI C NEUMANN J BRUTON J CHAMPLIN R
Citation: B. Abbott et al., STANDARD PRACTICE PROTOCOL OF GRANISETRON (KYTRIL(R)) FOR ANTIEMETIC CONTROL IN BONE-MARROW TRANSPLANT (BMT) PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION (TBI), Blood, 88(10), 1996, pp. 3737-3737
MICRODOSE METHOTREXATE VS METHYLPREDNISOLONE IN COMBINATION WITH TACROLIMUS FOR PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KHOURI I ANDERLINI P LEBHERZ D VANBESIEN K UENO N MEHRA R GIRALT S GAJEWSKI J FRITSCHE H CLEARY K CLAXTON D CHAMPLIN R ANDERSSON B KORBLING M
Citation: D. Przepiorka et al., MICRODOSE METHOTREXATE VS METHYLPREDNISOLONE IN COMBINATION WITH TACROLIMUS FOR PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Blood, 88(10), 1996, pp. 1659-1659
A PHASE I-II STUDY OF HIGH-DOSE THIOTEPA, BUSULFAN AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FOR AUTOLOGOUS TRANSPLANTATION FOR MALIGNANT-LYMPHOMA
Authors: PRZEPIORKA D NATH R IPPOLITI C MEHRA R HAGEMEISTER F DIENER K DIMOPOULOS M GIRALT S KHOURI I SAMUELS B VANBESIEN K ANDERSSON B DEISSEROTH AB LUNA M CABANILLAS F CHAMPLIN R
Citation: D. Przepiorka et al., A PHASE I-II STUDY OF HIGH-DOSE THIOTEPA, BUSULFAN AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FOR AUTOLOGOUS TRANSPLANTATION FOR MALIGNANT-LYMPHOMA, Leukemia & lymphoma, 17(5-6), 1995, pp. 427-433
DOSING OF THIOTEPA FOR MYELOABLATIVE THERAPY
Authors: PRZEPIORKA D MADDEN T IPPOLITI C ESTROV Z DIMOPOULOS M
Citation: D. Przepiorka et al., DOSING OF THIOTEPA FOR MYELOABLATIVE THERAPY, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 155-160
PREVENTION OF GRAFT-VERSUS-HOST-DISEASE WITH ANTI-CD5 RICIN-A CHAIN IMMUNOTOXIN AFTER CD3-DEPLETED HLA-NONIDENTICAL MARROW TRANSPLANTATION IN PEDIATRIC LEUKEMIA PATIENTS
Authors: PRZEPIORKA D CHAN KW CHAMPLIN RE CULBERT SJ PETROPOULOS D IPPOLITI C KHOURI I HUH YO VREISENDORP H DEISSEROTH AB BLEYER WA
Citation: D. Przepiorka et al., PREVENTION OF GRAFT-VERSUS-HOST-DISEASE WITH ANTI-CD5 RICIN-A CHAIN IMMUNOTOXIN AFTER CD3-DEPLETED HLA-NONIDENTICAL MARROW TRANSPLANTATION IN PEDIATRIC LEUKEMIA PATIENTS, Bone marrow transplantation, 16(6), 1995, pp. 737-741
INTRAVESICULAR CARBOPROST FOR THE TREATMENT OF HEMORRHAGIC CYSTITIS AFTER MARROW TRANSPLANTATION
Authors: IPPOLITI C PRZEPIORKA D MEHRA R NEUMANN J WOOD J CLAXTON D GAJEWSKI J KHOURI I VANBESIEN K ANDERSSON B DEISSEROTH AB DINNEY CP
Citation: C. Ippoliti et al., INTRAVESICULAR CARBOPROST FOR THE TREATMENT OF HEMORRHAGIC CYSTITIS AFTER MARROW TRANSPLANTATION, Urology, 46(6), 1995, pp. 811-815
TACROLIMUS VS CYCLOSPORINE FOR PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KHOURI I ANDERLINI P STEIN L VANBESIEN K MEHRA R GIRALT S GAJEWSKI J FRITSCHE H DEISSEROTH AB CLEARY K CHAMPLIN R ANDERSSON B KORBLING M
Citation: D. Przepiorka et al., TACROLIMUS VS CYCLOSPORINE FOR PREVENTION OF ACUTE GRAFT-VS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Blood, 86(10), 1995, pp. 1568-1568
Risultati: 1-25 | 26-41